
New COVID-19 Vaccine Formula Extends Antibody Duration, Emory Study Finds
A 2023 updated COVID-19 vaccine developed by Emory University produces antibodies with a half-life of over 500 days, about three times longer than previous versions, and offers broad protection against multiple strains, highlighting the importance of updated immunizations in combating the evolving virus.









